PFE

Pfizer

Health Care

Pharmaceuticals

New York City, New York

Balance Sheet 39 Accounts • 5 Years

Account	2024	2023	2022	2021	2020
end	2024-12-31	2023-12-31	2022-12-31	2021-12-31	2020-12-31
Assets - CashAndCashEquivalents	$1.0B	$2.9B	$416.0M	$1.9B	$1.8B
Assets - MarketableSecuritiesCurrent	$10.9B	$4.4B	$18.7B	$22.0B	$9.7B
Assets - AccountsReceivable	$11.5B	$11.6B	$11.0B	$11.5B	$7.9B
Assets - Inventories	$10.9B	$10.2B	$9.0B	$9.1B	$8.0B
Assets - PrepaidExpensesAndOtherCurrentAssets	$4.3B	$4.9B	$5.0B	$3.8B	$3.6B
Assets - TotalCurrentAssets	$50.4B	$43.3B	$51.3B	$59.7B	$35.1B
Assets - Property,PlantAndEquipment	$18.4B	$18.9B	$16.3B	$14.9B	$13.7B
Assets - Goodwill	$68.5B	$67.8B	$51.4B	$49.2B	$49.6B
Assets - IntangibleAssets(net,ExcludingGoodwill)	$55.4B	$64.9B	$43.4B	$25.1B	$28.3B
Assets - OperatingLeaseAssets	$2.3B	$2.9B	$3.0B	$2.8B	$1.4B
Assets - MarketableSecuritiesNoncurrent	$0	$150.0M	$352.0M	$521.0M	$128.0M
Assets - DeferredTaxAssets	$17.5B	$17.3B	$13.3B	$9.0B	$7.6B
Assets - OtherNoncurrentAssets	$9.8B	$12.5B	$13.2B	$7.7B	$4.9B
Assets - TotalAssets	$213.4B	$226.5B	$197.2B	$181.5B	$154.2B
Liabilities - AccountsPayable	$5.6B	$6.7B	$6.8B	$5.6B	$4.3B
Liabilities - AccruedLiabilities	$6.3B	$5.1B	$5.7B	$5.6B	$5.2B
Liabilities - ContractLiabilitiesCurrent(deferredRevenue)	$1.5B	$2.7B	$2.5B	$3.1B	$1.1B
Liabilities - ShortTermDebtAndCurrentPortionOfLongTermDebt	$6.9B	$10.3B	$2.9B	$2.2B	$2.7B
Liabilities - OperatingLeaseLiabilitiesCurrent	$356.0M	$527.0M	$620.0M	$449.0M	$320.0M
Liabilities - ContingentConsiderationLiabilityCurrent	$39.0M	$179.0M	$42.0M	$135.0M	$123.0M
Liabilities - OtherCurrentLiabilities	$19.7B	$20.5B	$22.6B	$24.9B	$11.6B
Liabilities - TotalCurrentLiabilities	$43.0B	$47.8B	$42.1B	$42.7B	$25.9B
Liabilities - LongTermDebt	$57.4B	$61.5B	$32.9B	$36.2B	$37.1B
Liabilities - OperatingLeaseLiabilitiesNoncurrent	$2.3B	$2.6B	$2.6B	$2.5B	$1.1B
Liabilities - DeferredTaxLiabilitiesNoncurrent	$2.1B	$640.0M	$1.0B	$349.0M	$4.1B
Liabilities - ContingentConsiderationLiabilityNoncurrent	$477.0M	$512.0M	$603.0M	$563.0M	$566.0M
Liabilities - OtherNoncurrentLiabilities	$14.2B	$16.5B	$13.2B	$9.7B	$6.7B
Liabilities - TotalLiabilities	$124.9B	$137.2B	$101.3B	$104.0B	$90.8B
Equity - PreferredStock	$27.0M	$0	$0	$0	$0
Equity - CommonStock	$480.0M	$478.0M	$476.0M	$473.0M	$470.0M
Equity - AdditionalPaidInCapital	$93.6B	$92.6B	$91.8B	$90.6B	$88.7B
Equity - RetainedEarnings(deficit)	$116.7B	$118.4B	$125.7B	$103.4B	$90.4B
Equity - AccumulatedOtherComprehensiveIncome(loss)	$-7.8B	$-8.0B	$-8.3B	$-5.9B	$-5.3B
Equity - NoncontrollingInterest(permanentEquity)	$294.0M	$274.0M	$256.0M	$262.0M	$235.0M
Equity - TotalStockholdersEquity	$88.2B	$89.0B	$95.7B	$77.2B	$63.2B
Equity - TotalLiabilitiesAndStockholdersEquity	$213.4B	$226.5B	$197.2B	$181.5B	$154.2B
Equity - TotalLiabilitiesandEquity	$213.1B	$226.2B	$196.9B	$181.2B	$154.0B
Validation - L+E Components Sum Difference	$0	$0	$0	$0	$0

Income Statement 27 Accounts • 5 Years

Account	2024	2023	2022	2021	2020
end	2024-12-31	2023-12-31	2022-12-31	2021-12-31	2020-12-31
IncomeStatement - Revenues - NetProductSales/Revenues	$63.6B	$59.6B	$101.2B	$81.3B	$41.7B
IncomeStatement - CostsAndExpenses - CostOfGoodsSold	$17.9B	$25.0B	$34.3B	$30.8B	$8.5B
IncomeStatement - CostsAndExpenses - ResearchAndDevelopmentExpense	$10.8B	$10.7B	$11.4B	$10.4B	$8.7B
IncomeStatement - CostsAndExpenses - Selling,GeneralAndAdministrative(andMarketing)	$14.7B	$14.8B	$13.7B	$12.7B	$11.6B
IncomeStatement - CostsAndExpenses - AmortizationOfIntangibleAssets(operating)	$5.3B	$4.7B	$3.6B	$3.7B	$3.4B
IncomeStatement - CostsAndExpenses - Depreciation(operating)	$7.0B	$6.3B	$5.1B	$5.2B	$4.7B
IncomeStatement - CostsAndExpenses - RestructuringAndImpairmentCharges	$2.0B	$2.0B	$882.0M	$741.0M	$535.0M
IncomeStatement - CostsAndExpenses - AcquisitionAndIntegrationCosts	$427.0M	$785.0M	$348.0M	$41.0M	$34.0M
IncomeStatement - OtherIncomeExpense - InterestExpense	$3.1B	$2.2B	$1.2B	$1.3B	$1.4B
IncomeStatement - OtherIncomeExpense - InterestIncome	$545.0M	$1.6B	$251.0M	$36.0M	$73.0M
IncomeStatement - OtherIncomeExpense - Gain(loss)OnInvestments/EquityMethod	$1.0B	$1.6B	$-1.3B	$1.3B	$540.0M
IncomeStatement - OtherIncomeExpense - LitigationSettlements(gain/loss)	$-567.0M	$-474.0M	$-230.0M	$-182.0M	$-28.0M
IncomeStatement - OtherIncomeExpense - OtherNonoperatingIncome(expense)	$-4.4B	$-222.0M	$-1.1B	$4.9B	$-1.2B
IncomeStatement - OtherIncomeExpense - Income(loss)FromContinuingOperationsBeforeIncomeTaxes	$8.0B	$1.1B	$34.7B	$24.3B	$7.0B
IncomeStatement - IncomeTax - IncomeTaxExpense(benefit)	$-28.0M	$-1.1B	$3.3B	$1.9B	$370.0M
IncomeStatement - IncomeTax - EffectiveTaxRate(continuingOperations)	$-0	$-1	$0	$0	$0
IncomeStatement - DiscontinuedOperations - Income(loss)FromDiscontinuedOperations,NetOfTax	$11.0M	$-15.0M	$6.0M	$-434.0M	$2.5B
IncomeStatement - NetIncomeAndEps - Income(loss)FromContinuingOperations	$8.1B	$2.2B	$31.4B	$22.4B	$6.6B
IncomeStatement - NetIncomeAndEps - NetIncome(loss)	$8.0B	$2.1B	$31.4B	$22.0B	$9.2B
IncomeStatement - NetIncomeAndEps - NetIncome(loss)AttributableToNoncontrollingInterest	$31.0M	$39.0M	$35.0M	$45.0M	$36.0M
IncomeStatement - NetIncomeAndEps - NetIncome(loss)AttributableToCompany	$8.0B	$2.1B	$31.4B	$22.0B	$9.2B
IncomeStatement - NetIncomeAndEps - BasicEarningsPerShare	$1	$0	$6	$4	$2
IncomeStatement - NetIncomeAndEps - DilutedEarningsPerShare	$1	$0	$5	$4	$2
IncomeStatement - NetIncomeAndEps - WeightedAverageSharesOutstandingBasic	$5.7B	$5.6B	$5.6B	$5.6B	$5.6B
IncomeStatement - NetIncomeAndEps - WeightedAverageSharesOutstandingDiluted	$5.7B	$5.7B	$5.7B	$5.7B	$5.6B
IncomeStatement - NetIncomeAndEps - ComprehensiveIncome(loss)	$8.1B	$2.5B	$29.0B	$21.4B	$9.6B

Cash Flow Statement 23 Accounts • 5 Years

Account	2024	2023	2022	2021	2020
end	2024-12-31	2023-12-31	2022-12-31	2021-12-31	2020-12-31
CashFlow - OperatingActivities - NetIncome	$8.0B	$2.1B	$31.4B	$22.0B	$9.2B
CashFlow - OperatingActivities - DepreciationAndAmortization	$7.0B	$6.3B	$5.1B	$5.2B	$4.7B
CashFlow - OperatingActivities - ShareBasedCompensation	$877.0M	$525.0M	$872.0M	$1.2B	$755.0M
CashFlow - OperatingActivities - DeferredIncomeTaxes	$-2.1B	$-3.4B	$-3.8B	$-4.3B	$-1.6B
CashFlow - OperatingActivities - ChangesInOperatingAssetsAndLiabilities	$-5.6B	$2.4B	$3.6B	$20.9B	$3.7B
CashFlow - OperatingActivities - NetCashFromOperatingActivities(continuingOperations)	$12.7B	$8.7B	$29.3B	$32.9B	$10.5B
CashFlow - InvestingActivities - CapitalExpenditures(pp&e&Intangibles)	$2.9B	$3.9B	$3.2B	$2.7B	$2.2B
CashFlow - InvestingActivities - AcquisitionsOfBusinesses,NetOfCash	$0	$43.4B	$23.0B	$0	$0
CashFlow - InvestingActivities - PurchasesOfMarketableSecurities/investments	$180.0M	$204.0M	$1.9B	$1.1B	$597.0M
CashFlow - InvestingActivities - OtherInvestingActivities	$-2.0M	$179.0M	$192.0M	$305.0M	$265.0M
CashFlow - InvestingActivities - NetCashFromInvestingActivities(continuingOperations)	$2.7B	$-32.3B	$-15.8B	$-22.5B	$-4.2B
CashFlow - FinancingActivities - ProceedsFromIssuanceOfDebt	$0	$30.8B	$0	$997.0M	$5.2B
CashFlow - FinancingActivities - RepaymentsOfDebt	$2.2B	$2.6B	$3.3B	$2.0B	$4.0B
CashFlow - FinancingActivities - PaymentsForRepurchaseOfCommonStock	$0	$0	$2.0B	$0	$0
CashFlow - FinancingActivities - PaymentOfDividends	$9.6B	$9.3B	$9.0B	$8.8B	$8.6B
CashFlow - FinancingActivities - OtherFinancingActivities	$-469.0M	$-631.0M	$-335.0M	$16.0M	$-444.0M
CashFlow - FinancingActivities - NetCashFromFinancingActivities(continuingOperations)	$-17.1B	$26.1B	$-14.8B	$-9.8B	$-21.6B
CashFlow - CashReconciliationAndSupplemental - EffectOfExchangeRateChangesOnCash	$-66.0M	$-40.0M	$-165.0M	$-59.0M	$-8.0M
CashFlow - CashReconciliationAndSupplemental - NetChangeInCash	$-1.8B	$2.4B	$-1.5B	$159.0M	$475.0M
CashFlow - CashReconciliationAndSupplemental - IncomeTaxesPaid	$3.6B	$3.1B	$7.9B	$7.4B	$3.2B
CashFlow - CashReconciliationAndSupplemental - InterestPaid	$3.2B	$2.2B	$1.4B	$1.5B	$1.6B
CashFlow - CashReconciliationAndSupplemental - RightOfUseAssetsObtainedForLeases(nonCash)	$283.0M	$614.0M	$752.0M	$1.9B	$410.0M

Pfizer

Balance Sheet 39 Accounts • 5 Years

Income Statement 27 Accounts • 5 Years

Cash Flow Statement 23 Accounts • 5 Years

Stock Market Data (1 Year) Live Yahoo Finance Data

Recent Price History